Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov;35(6):585-591.
doi: 10.6515/ACS.201911_35(6).20190327A.

Effects of Levosimendan on Right Ventricular Function in Patients with Acute Decompensated Heart Failure

Yan-Bo Wang  1 , Guo-Zhen Hao  1 , Yun-Fa Jiang  1 , Xiang-Hua Fu  1 , Wei-Ze Fan  1 , Qing Miao  1 , Qing Wang  1 , Hong-Xiao Li  1 , Xin-Shun Gu  1
Affiliations

Effects of Levosimendan on Right Ventricular Function in Patients with Acute Decompensated Heart Failure

Yan-Bo Wang et al. Acta Cardiol Sin. 2019 Nov.

Abstract

Background: To investigate the effects of levosimendan on right ventricular (RV) function in patients with acute decompensated heart failure (ADHF).

Methods: Patients with ADHF admitted from January 2017 to October 2017 were enrolled in this study. The patients were randomized to receive 24-h intravenous levosimendan or placebo. Echocardiographic examinations were performed and the parameters were compared. Epidemiological data were recorded and compared before and after treatment. Major adverse cardiac events during hospitalization and during 1-month follow-up were compared.

Results: The baseline characteristics were comparable. After 24-h infusion of levosimendan and placebo, the left ventricular ejection fraction and S' were significantly increased in the levosimendan group compared with the control group (both p < 0.05). The E value in the levosimendan group significantly decreased (75.38 ± 8.32 vs. 88.21 ± 10.36, p < 0.0001), and E/e' significantly increased in the control group (19.61 ± 6.52 vs. 27.58 ± 8.22, p < 0.0001). The levels of right ventricular fractional area change (24 ± 3 vs. 20 ± 2, p < 0.0001) and tricuspid annular plane systolic excursion (1.56 ± 0.36 vs. 1.38 ± 0.21, p < 0.0001) were significantly higher in the levosimendan group than in the control group. After treatment, the values of systolic pulmonary artery pressure (SPAP) decreased in both groups (both p < 0.05), and the value of SPAP in the levosimendan group was lower than that in the control group (47.22 ± 5.6 vs. 55.85 ± 7.41, p < 0.0001). After 1-month follow-up, there was no significance in readmissions due to recurrent heart failure.

Conclusions: Levosimendan seems to provide more beneficial effects among patients with ADHF to improve RV function, along with a decrease in pulmonary pressure.

Keywords: Acute decompensated heart failure; Echocardiography; Levosimendan; Right ventricular function.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patients’ selection flow diagram. ADHF, acute decompensated heart failure.
See this image and copyright information in PMC

References

    1. Orriach Guerrero JL, Ramirez Fernandez A, Iglesias P, et al. Preoperative levosimendan. A new way for organoprotection. Curr Pharm Des. 2014;20:5476–5483. - PubMed
    1. Chang HY, Wang CC, Wu YW, et al. One-year outcomes of acute decompensated systolic heart failure in Taiwan: lessons from TSOC-HFrEF Registry. Acta Cardiol Sin. 2017;33:127–138. - PMC - PubMed
    1. Guerrero-Orriach JL, Ariza-Villanueva D, Florez-Vela A, et al. Cardiac, renal, and neurological benefits of preoperative levosimendan administration in patients with right ventricular dysfunction and pulmonary hypertension undergoing cardiac surgery: evaluation with two biomarkers neutrophil gelatinase-associated lipocalin and neuronal enolase. Ther Clin Risk Manag. 2016;12:623–630. - PMC - PubMed
    1. Humbert M, Sitbon O, Chaouat A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation. 2010;122:156–163. - PubMed
    1. D’Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Ann Intern Med. 1991;115:343. - PubMed

LinkOut - more resources